In this triple-blind clinical trial, 90 overweight or obese children and adolescents aged 9-18 years are randomly selected. Written informed consent will be obtained from parents. Inclusion criteria include age (9-18 years), and body mass index (BMI) above 85th centile for age and sex. Hypothyroidism, medical therapy for dyslipidemia, smoking or exposure to tobacco are considered as exclusion criteria. Demographic and anthropometric characteristics including age, sex, weight, height and BMI will be recorded. Lipid profile and flow-mediated dilation (FMD) showing endothelial dysfunction will be measured at baseline and end of the study.
Participants will randomly assigned to three groups (each group includes 30 subjects), receiving citrus aurantium or citrus aurantifolia extracts or placebo (corn starch) capsules (1 capsule/12 hour), respectively. The study will last for one month. Statistical analysis will be conducted using SPSS version 20, Paired t-test, Analysis of Variance (ANOVA), and Post-hoc analysis will be used to test significant differences between study groups.